Genmab shares climb after lymphoma therapy hits goal in trial
- Posted on June 30, 2026
- By Bing News
- 0 Views
- 1 min read
Genmab shares climb after lymphoma therapy hits goal in trial
The Danish biotechnology company and partner AbbVie said a drug combination to treat lymphoma met the primary goal in a late-stage clinical trial.
